BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 477969)

  • 21. [Chemistry and pharmacology of pyran derivatives. XVII. Synthesis of 2-(dialkylamino)-5-hydroxychromones and their transformation to derivatives of 2H-pyran[4,3,2-de]-1-benzopyran].
    Mazzei M; Ermili A; Balbi A; Di Braccio M; Schiantarelli P; Cadel S
    Farmaco Sci; 1986 Aug; 41(8):611-21. PubMed ID: 3743752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 2H,5H-[1]benzothiopyrano [4,3-b]pyran derivatives with platelet antiaggregating activity.
    Bargagna A; Longobardi M; Mariani E; Schenone P; Losasso C; Esposito G; Falzarano C; Marmo E
    Farmaco; 1990 Apr; 45(4):405-13. PubMed ID: 2400515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [1,4-Disubstituted 1,3-dihydro-2H-1,5-benzo- and chlorobenzodiazepin-2-ones with activity on the central nervous system].
    Savelli F; Boido A; Mulè A; Piu L; Alamanni MC; Pirisino G; Satta M; Peana A
    Farmaco; 1989 Feb; 44(2):125-40. PubMed ID: 2775411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Chemical and pharmacologic study on pyran derivatives. IX. Synthesis of 2-dialkylaminochromones].
    Ermili A; Balbi A; Di Braccio M; Roma G
    Farmaco Sci; 1977 Oct; 32(10):713-24. PubMed ID: 200470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 2H-[1]benzothiepino [5,4-b]pyran derivatives with local anesthetic and antiarrhythmic activities.
    Longobardi M; Bargagna A; Mariani E; Schenone P; Vitagliano S; Stella L; Di Sarno A; Marmo E
    Farmaco; 1990 Apr; 45(4):399-404. PubMed ID: 2400514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and antimicrobial activities of novel naphtho[2,1-b]pyran, pyrano[2,3-d]pyrimidine and pyrano[3,2-e][1,2,4]triazolo[2,3-c]-pyrimidine derivatives.
    Bedair AH; Emam HA; El-Hady NA; Ahmed KA; El-Agrody AM
    Farmaco; 2001 Dec; 56(12):965-73. PubMed ID: 11829118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and antimicrobial evaluation of naphtho[2,1-b]pyrano[2,3-d]pyrimidine and pyrano[3,2-e][1,2,4]triazolo[1,5-c]pyrimidine derivatives.
    Eid FA; Abd El-Wahab AH; Ali GA; Khafagy MM
    Acta Pharm; 2004 Mar; 54(1):13-26. PubMed ID: 15050041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [1,5-benzodiazepines. V. Synthesis of pyrazolo (3,4-b)(1,5)benzodiazepines and 5H-pyrimido(4,5-b)(1,5)benzodiazepines].
    Roma G; Balbi A; Ermili A; Vigevani E
    Farmaco Sci; 1983 Aug; 38(8):546-58. PubMed ID: 6137413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthetic routes to fluorenone, indenopyirdine, 4h-naphtho[2,1-b]pyrans and pyridine derivatives.
    el-Taweel FM; Sofan MA; el-Maati TM; Elagamey AA
    Boll Chim Farm; 2001; 140(5):306-10. PubMed ID: 11680083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Derivatives of 1,2-condensed pyrimidines. II. Synthesis and pharmacological study of N,N-disubstituted 5-amino-7H-thiazol [3,2-a]pyrimdine-7-ones].
    Di Braccio M; Roma G; Mazzei M; Balbi A; Testa R
    Farmaco Sci; 1986 Mar; 41(3):183-95. PubMed ID: 3486780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and evaluation of anticonvulsant and antimicrobial activities of 3-hydroxy-6-methyl-2-substituted 4h-pyran-4-one derivatives.
    Aytemir MD; Caliş U; Ozalp M
    Arch Pharm (Weinheim); 2004 May; 337(5):281-8. PubMed ID: 15095421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N,N-disubstituted 4-amino-(6-methoxy)-3-phenyl-2H-naphtho [1,2-b]pyran-2-ones with antiarrhythmic, platelet antiaggregating and local anesthetic activities.
    Bargagna A; Longobardi M; Mariani E; Schenone P; Russo S; Vilagliano S; De Novellis V; Marmo E
    Farmaco Sci; 1988 Nov; 43(11):857-77. PubMed ID: 3251781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 2H-pyrano[3,2-d]-1-benzoxepin derivatives with platelet antiaggregating and other activities.
    Longobardi M; Bargagna A; Mariani E; Schenone P; Losasso C; Cenicola ML; D'Antonio M; Marmo E
    Farmaco; 1991 Mar; 46(3):449-60. PubMed ID: 1892502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Practical and efficient synthesis of pyrano[3,2-c]pyridone, pyrano[4,3-b]pyran and their hybrids with nucleoside as potential antiviral and antileishmanial agents.
    Fan X; Feng D; Qu Y; Zhang X; Wang J; Loiseau PM; Andrei G; Snoeck R; De Clercq E
    Bioorg Med Chem Lett; 2010 Feb; 20(3):809-13. PubMed ID: 20064723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Derivatives of pyrimidine 1,2-condensate. IV. Synthesis and pharmacological properties of the N,N-disubstituted 4-amino-2H-pyrido(1,2-a)pyrimidin- 2-ones and 2-amino-4H-pyrido(1,2-a)pyrmidin-4-ones].
    Di Braccio M; Roma G; Mazzei M; Balbi A; Schiantarelli P; Cadel S; Bongrani S
    Farmaco Sci; 1988 Sep; 43(9):705-23. PubMed ID: 3229496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of various radicinin analogs on pulse amplitude and arterial blood pressure].
    Cassone MC
    Boll Soc Ital Biol Sper; 1983 Jan; 59(1):71-7. PubMed ID: 6849695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 2H-pyrano[2,3-f]quinazoline derivatives with platelet antiaggregating and other activities.
    Longobardi M; Mariani E; Bargagna A; Schenone P; Budetta S; Losasso C; Cenicola ML; Donnoli D; De Santis D; Marmo E
    Farmaco; 1991 Jan; 46(1):99-110. PubMed ID: 2054045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis, reactions and biological evaluation of some new naphtho[2,1-b]furan derivatives bearing a pyrazole nucleus.
    El-Wahab AH; Al-Fifi ZI; Bedair AH; Ali FM; Halawa AH; El-Agrody AM
    Molecules; 2011 Jan; 16(1):307-18. PubMed ID: 21266944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and pharmacological properties of 13H-naphtho[1',2':7,6] [1,4] diazepino[2,3-b] pyridines.
    Kaczmarek L; Nantka-Namirski P; Dereń A; Chojnacka-Wójcik E
    Pol J Pharmacol Pharm; 1990; 42(2):165-75. PubMed ID: 2274474
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design and synthesis of new pyranoxanthenones bearing a nitro group or an aminosubstituted side chain on the pyran ring. Evaluation of their growth inhibitory activity in breast cancer cells.
    Kolokythas G; Kostakis IK; Pouli N; Marakos P; Kousidou OCh; Tzanakakis GN; Karamanos NK
    Eur J Med Chem; 2007 Mar; 42(3):307-19. PubMed ID: 17145121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.